Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
BioSpace
April 20, 2021
BioSpace
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that Michael Gaffney has joined the company as Chief Executive Officer, effective immediately.
Cellphire Therapeutics, Inc.
April 20, 2021
www.prnewswire.com:443
/PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across...
December 22, 2020
WebWire
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and BioIntelliSense, Inc. [1], a continuous health monitoring and clinical intelligence company, today announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense's FDA-cleared BioSticker device for the ea...
SkillPower
December 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- SkillPower, innovative provider of digital health technology, today announced it was named a finalist in the U.S. Army Medical Research and...
Empatica
November 6, 2020
www.prnewswire.com:443
/PRNewswire/ -- Empatica has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to deploy a wearable and algorithm that enable...
SHOW MORE